Alembic Ltd
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]
- Market Cap ₹ 2,841 Cr.
- Current Price ₹ 111
- High / Low ₹ 169 / 85.5
- Stock P/E 9.14
- Book Value ₹ 91.1
- Dividend Yield 2.17 %
- ROCE 6.95 %
- ROE 13.7 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 24.1%
Cons
- Tax rate seems low
- Company has a low return on equity of 11.6% over last 3 years.
- Earnings include an other income of Rs.74.9 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Realty Industry: Construction
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,121 | 144 | 134 | 147 | 125 | 124 | 74 | 74 | 78 | 127 | 157 | 222 | |
1,018 | 134 | 128 | 140 | 114 | 106 | 71 | 62 | 64 | 87 | 101 | 128 | |
Operating Profit | 103 | 10 | 6 | 7 | 11 | 18 | 3 | 11 | 14 | 40 | 57 | 94 |
OPM % | 9% | 7% | 5% | 5% | 9% | 15% | 4% | 15% | 18% | 32% | 36% | 42% |
16 | 21 | 25 | 25 | 37 | 29 | 93 | 10 | 89 | 54 | 55 | 75 | |
Interest | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
Depreciation | 43 | 6 | 6 | 5 | 4 | 3 | 3 | 4 | 5 | 7 | 8 | 11 |
Profit before tax | 44 | 23 | 25 | 27 | 44 | 45 | 93 | 17 | 98 | 87 | 103 | 156 |
Tax % | 10% | -3% | 2% | -3% | 5% | 8% | 0% | 19% | 12% | 7% | 10% | 7% |
40 | 107 | 235 | 145 | 163 | 213 | 329 | 343 | 222 | 191 | 269 | 311 | |
EPS in Rs | 1.48 | 3.99 | 8.78 | 5.45 | 6.10 | 8.30 | 12.82 | 13.35 | 8.65 | 7.42 | 10.46 | 12.10 |
Dividend Payout % | 17% | 4% | 2% | 4% | 3% | 2% | 5% | 2% | 21% | 30% | 23% | 20% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 25% |
3 Years: | 42% |
TTM: | 41% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | -1% |
3 Years: | 12% |
TTM: | 16% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 16% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 12% |
3 Years: | 12% |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 27 | 53 | 53 | 53 | 53 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
Reserves | 311 | 474 | 750 | 858 | 1,032 | 1,157 | 1,367 | 2,246 | 2,445 | 2,027 | 2,134 | 2,287 |
408 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 14 | |
251 | 91 | 64 | 81 | 73 | 57 | 53 | 112 | 135 | 127 | 134 | 150 | |
Total Liabilities | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 |
393 | 169 | 146 | 171 | 179 | 209 | 225 | 265 | 297 | 321 | 369 | 409 | |
CWIP | 4 | 2 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 1 | 0 |
Investments | 8 | 299 | 605 | 732 | 913 | 1,001 | 1,133 | 2,047 | 2,208 | 1,754 | 1,786 | 1,900 |
591 | 149 | 124 | 89 | 67 | 55 | 110 | 91 | 127 | 130 | 173 | 194 | |
Total Assets | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
149 | 22 | 10 | 52 | 24 | 22 | 7 | -2 | -18 | 39 | 23 | 86 | |
-24 | 5 | -5 | -47 | -22 | 68 | 57 | -35 | 19 | 7 | 26 | -27 | |
-118 | -25 | -5 | -5 | -3 | -89 | -6 | -15 | -6 | -46 | -48 | -58 | |
Net Cash Flow | 7 | 2 | -0 | -0 | -1 | 1 | 57 | -52 | -5 | -0 | 0 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 63 | 122 | 76 | 54 | 74 | 40 | 44 | 69 | 71 | 67 | 46 | 49 |
Inventory Days | 158 | 880 | 659 | 438 | 247 | 289 | 411 | 2,112 | 2,885 | 3,694 | 525 | |
Days Payable | 128 | 200 | 144 | 128 | 125 | 202 | 151 | 693 | 640 | 1,237 | 149 | |
Cash Conversion Cycle | 93 | 801 | 591 | 364 | 195 | 126 | 305 | 1,488 | 2,316 | 67 | 2,502 | 425 |
Working Capital Days | 108 | 235 | 172 | 39 | 20 | 13 | 22 | 98 | 223 | 118 | 81 | 154 |
ROCE % | 10% | 4% | 4% | 4% | 4% | 7% | 1% | 4% | 4% | 5% | 7% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
2d - Alembic Limited's Annual Secretarial Compliance Report for FY ended March 31, 2025 confirms regulatory compliance.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 May - Copy of Notice w.r.t. transfer of Equity Shares of the Company to Investor Education and Protection Fund (IEPF), published in Indian Express (English Edition) and …
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ("Listing Regulations, 2015")
15 May - Reminder to shareholders to claim unpaid dividends before shares transfer to IEPF on 14/08/2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 May - Newspaper cuttings related to advertisement published for Audited Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2025, in …
-
Intimation For Amendments Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
13 May - Alembic reports FY25 audited results; recommends Rs 2.40 dividend; appoints secretarial auditor; financials show strong growth.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Business Segments
A) Real Estate (~80% in FY24 vs 59% in FY22): [1] [2] The company is involved in the construction of residential & commercial real estate projects. It also leases commercial properties. [3] Real Estate business experienced strong growth between FY23-FY24 bolstered by strong demand and higher property prices. [4]